Unknown

Dataset Information

0

Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity.


ABSTRACT: Proteasomal protein degradation is a promising target for cancer therapy. Here, we developed a positron emission tomography (PET) technique based on the sodium-iodide symporter (NIS) gene fused with the carboxyl-terminal of ornithine decarboxylase (cODC) that noninvasively images cancer cells with inhibited proteasome activity. A retroviral vector was constructed in which the murine cODC degron was fused to the human NIS gene (NIS-cODC). Transiently transduced CT26 and HT29 colon cancer cells and stably expressing CT26/NIS-cODC cells were prepared. In cancer cells transiently transduced with NIS-cODC, NIS expression and transport activity was low at baseline, but NIS protein and 125I uptake was significantly increased by inhibition of proteasome activity with bortezomib. Stable CT26/NIS-cODC cells also showed increased cytosolic and membrane NIS by bortezomib, and four different stable clones displayed bortezomib dose-dependent stimulation of 125I and 99mTc-04- uptake. Importantly, bortezomib dose-dependently suppressed survival of CT26/NIS-cODC clones in a manner that closely correlated to the magnitudes of 125I and 99mTc-04- uptake. CT26/NIS-cODC tumors of bortezomib-treated mice demonstrated greater 124I uptake on PET images and increased NIS expression on tissue staining compared to vehicle-injected animals. NIS-cODC PET imaging may allow noninvasive quantitative monitoring of proteasome activity in cancer cells treated with bortezomib.

SUBMITTER: Lee JH 

PROVIDER: S-EPMC6095884 | biostudies-other | 2018 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity.

Lee Jin Hee JH   Jung Kyung-Ho KH   Quach Cung Hoa Thien CHT   Park Jin Won JW   Moon Seung Hwan SH   Cho Young Seok YS   Lee Kyung-Han KH  

Scientific reports 20180816 1


Proteasomal protein degradation is a promising target for cancer therapy. Here, we developed a positron emission tomography (PET) technique based on the sodium-iodide symporter (NIS) gene fused with the carboxyl-terminal of ornithine decarboxylase (cODC) that noninvasively images cancer cells with inhibited proteasome activity. A retroviral vector was constructed in which the murine cODC degron was fused to the human NIS gene (NIS-cODC). Transiently transduced CT26 and HT29 colon cancer cells an  ...[more]

Similar Datasets

| S-EPMC8150958 | biostudies-literature
| S-EPMC4848511 | biostudies-literature
| S-EPMC2535907 | biostudies-literature
| S-EPMC4141551 | biostudies-literature
| S-EPMC5638992 | biostudies-literature
| S-EPMC5673231 | biostudies-literature
| S-EPMC5406460 | biostudies-other
| S-EPMC9221333 | biostudies-literature
| S-EPMC4864285 | biostudies-literature
| S-EPMC3303152 | biostudies-literature